Skip to main content
. 2018 Jan 17;11:8. doi: 10.1186/s13048-018-0380-5

Fig. 2.

Fig. 2

Development of OC and tumor size. a Incidence rate (%) of developed OC from 1 to 8 months after DMBA infusion. b The tumor volume (mm3) was measured throughout the experiment. * P < 0.05 vs. the OC group; # P < 0.05 vs. the OC + P-MAPA group. c The tumor mass (g) was recorded at the end of treatments. * P < 0.05 vs. the OC group